| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1098-2744(200011)29:3<143::AID-MC3>3.0.CO;2-A |
| P698 | PubMed publication ID | 11108659 |
| P2093 | author name string | J Liu | |
| J Kagan | |||
| M Liebert | |||
| D C Babaian | |||
| P A Steck | |||
| P2860 | cites work | Germline mutations in PTEN are present in Bannayan-Zonana syndrome | Q48046915 |
| Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization | Q57274845 | ||
| Chromosomes in kidney, ureter, and bladder cancer | Q69587661 | ||
| Genetic alterations in bladder cancer | Q72228488 | ||
| PTEN germ-line mutations in juvenile polyposis coli | Q74026971 | ||
| Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer | Q74250427 | ||
| P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
| Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases | Q24323070 | ||
| Crystal structure of human protein tyrosine phosphatase 1B | Q27731235 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| PTEN1 is frequently mutated in primary endometrial carcinomas | Q28250937 | ||
| Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms | Q28256462 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome | Q29615538 | ||
| Recognition and specificity in protein tyrosine kinase-mediated signalling | Q30192978 | ||
| Cancer statistics, 2000. | Q33895772 | ||
| Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. | Q34742581 | ||
| 1002 protein phosphatases? | Q35237461 | ||
| Chromosomal analysis of bladder cancer. III. Nonrandom alterations | Q39673036 | ||
| PDZ domains bind carboxy-terminal sequences of target proteins | Q41331117 | ||
| Bladder cancer: natural history, tumor markers, and early detection strategies | Q41564491 | ||
| PDZ domains and the formation of protein networks at the plasma membrane. | Q41662760 | ||
| Cytogenetic investigation on 30 bladder carcinomas | Q44584989 | ||
| Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers | Q47814180 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 143-150 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Molecular Carcinogenesis | Q15724597 |
| P1476 | title | Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens | |
| P478 | volume | 29 |
| Q40256804 | A role for Akt in the rapid regulation of inflammatory and apoptotic pathways in mouse bladder |
| Q33554361 | Biology of urothelial tumorigenesis: insights from genetically engineered mice |
| Q37770780 | Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium |
| Q33611551 | Different molecular patterns in glioblastoma multiforme subtypes upon recurrence |
| Q92200712 | Evaluation of PTEN and CD4+FOXP3+ T cell expressions as diagnostic and predictive factors in endometrial cancer: A case control study |
| Q61804671 | Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms |
| Q30432032 | Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma |
| Q37243937 | Molecular pathogenesis of bladder cancer |
| Q36341182 | Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? |
| Q30434033 | PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity |
| Q33554443 | Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer |
| Q54619617 | Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcoma. |
| Q30311889 | Review Article: The Role of Ras Superfamily Proteins in Bladder Cancer Progression |
| Q38090432 | The regulatory roles of phosphatases in cancer |
| Q37270420 | The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey |
Search more.